ImageneBio Inc(IMA)

$5.62—

Chart

ImageneBio Inc(IMA)

NASDAQ

$5.62—

Chart Studio

IMA(IMA)

IMA

Overview Fair Value Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q4 2026 EPS Estimate

$-0.76

Nov 11, 2026

Analyst Sentiment

Wall St. Consensus

Buy

5 analysts·Limited coverage

Score

4 Buy (80%)0 Hold (0%)1 Sell (20%)

Rating Breakdown

Strong Buy

00%

Buy

480%

Hold

00%

Sell

120%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$1.33

-76.3%

Consensus

$1.33

-76.3%

Bull

$1.33

-76.3%

12-Month Target Range5 analysts

$1.33$1.33$1.33

Current $5.62Consensus

Current Price

$5.62

Above Consensus

$4.29

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev-57.47%

EPS—

FY2028

Rev-57.47%

EPS—

FY2029

Rev-57.47%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$340,244	$144,707	$61,544	$26,175	$21M
Low	$340,244	$144,707	$61,544	$26,175	$21M
High	$340,244	$144,707	$61,544	$26,175	$21M
EBITDA Avg	$-340,244	$-144,707	$-61,544	$-26,175	$-21M
Low	$-340,244	$-144,707	$-61,544	$-26,175	$-21M
High	$-340,244	$-144,707	$-61,544	$-26,175	$-21M
EBIT Avg	$-340,244	$-144,707	$-61,544	$-26,175	$-21M
Low	$-340,244	$-144,707	$-61,544	$-26,175	$-21M
High	$-340,244	$-144,707	$-61,544	$-26,175	$-21M
Net Income Avg	$-15M	$-17M	$-14M	$-16M	$-18M
Low	$-16M	$-25M	$-25M	$-16M	$-18M
High	$-15M	$-8M	$-3M	$-16M	$-18M
EPS Avg	$-3.14	$-3.45	$-3.73	$-3.28	$-3.78
Low	$-3.22	$-5.16	$-5.05	$-3.28	$-3.78
High	$-3.05	$-1.73	$-0.72	$-3.28	$-3.78
Analysts (Rev / EPS)	4 / 3	4 / 3	4 / 4	2 / 1	2 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	—	—	—	—	—	—	—	—
Low	—	—	—	—	—	—	—	—
High	—	—	—	—	—	—	—	—
EBITDA Avg	—	—	—	—	—	—	—	—
Low	—	—	—	—	—	—	—	—
High	—	—	—	—	—	—	—	—
EBIT Avg	—	—	—	—	—	—	—	—
Low	—	—	—	—	—	—	—	—
High	—	—	—	—	—	—	—	—
Net Income Avg	$-13M	$-14M	$-17M	$-19M	$-21M	$-24M	$-9M	$-9M
Low	$-13M	$-15M	$-17M	$-19M	$-21M	$-24M	$-9M	$-9M
High	$-13M	$-14M	$-17M	$-19M	$-21M	$-24M	$-9M	$-9M
EPS Avg	$-0.79	$-0.89	$-1.06	$-1.15	$-1.28	$-1.51	$-0.55	$-0.57
Low	$-0.79	$-0.92	$-1.06	$-1.15	$-1.28	$-1.51	$-0.55	$-0.57
High	$-0.78	$-0.86	$-1.06	$-1.15	$-1.28	$-1.51	$-0.55	$-0.57
Analysts (Rev / EPS)	— / 2	— / 2	— / 1	— / 1	— / 1	— / 1	— / 1	— / 1

Earnings Surprises

Recent Analyst Actions

May 29, 2024Wedbush

This American Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Target:$1.33

-18.9%from $1.64

May 29, 2024Wedbush

iKena Oncology downgraded to Neutral from Outperform at Wedbush

Target:$2.00

+50.4%from $1.33

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance